153 related articles for article (PubMed ID: 38195458)
21. Association of different patterns of expression of beta-catenin and cyclin D1 with pathogenesis of breast carcinoma.
Varma K; Chauhan A; Bhargava M; Misra V; Srivastava S
Indian J Pathol Microbiol; 2020; 63(1):13-18. PubMed ID: 32031116
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
Toya H; Oyama T; Ohwada S; Togo N; Sakamoto I; Horiguchi J; Koibuchi Y; Adachi S; Jigami T; Nakajima T; Akiyama T
Cancer Sci; 2007 Apr; 98(4):484-90. PubMed ID: 17309600
[TBL] [Abstract][Full Text] [Related]
23. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
24. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
[TBL] [Abstract][Full Text] [Related]
25. The Proliferation of Glioblastoma Is Contributed to Kinesin Family Member 18A and Medical Data Analysis of GBM.
Wang LB; Zhang XB; Liu J; Liu QJ
Front Genet; 2022; 13():858882. PubMed ID: 35464837
[No Abstract] [Full Text] [Related]
26. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
[TBL] [Abstract][Full Text] [Related]
27. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
[TBL] [Abstract][Full Text] [Related]
28. Determination of β-catenin Expression in Breast Cancer and Its Relationship with Clinicopathologic Parameters.
Sefidbakht S; Saeedipour H; Saffar H; Mirzaian E
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3493-3498. PubMed ID: 34837904
[TBL] [Abstract][Full Text] [Related]
29. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.
Geyer FC; Lacroix-Triki M; Savage K; Arnedos M; Lambros MB; MacKay A; Natrajan R; Reis-Filho JS
Mod Pathol; 2011 Feb; 24(2):209-31. PubMed ID: 21076461
[TBL] [Abstract][Full Text] [Related]
30. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
31. The expression of β-catenin in different subtypes of breast cancer and its clinical significance.
Li S; Li S; Sun Y; Li L
Tumour Biol; 2014 Aug; 35(8):7693-8. PubMed ID: 24801904
[TBL] [Abstract][Full Text] [Related]
32. Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse.
Khalil S; Tan GA; Giri DD; Zhou XK; Howe LR
PLoS One; 2012; 7(3):e33421. PubMed ID: 22457761
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma.
Tao BY; Liu YY; Liu HY; Zhang ZH; Guan YQ; Wang H; Shi Y; Zhang J
Front Genet; 2022; 13():852049. PubMed ID: 35591854
[No Abstract] [Full Text] [Related]
34. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
36. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
37. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer.
Ozaki S; Ikeda S; Ishizaki Y; Kurihara T; Tokumoto N; Iseki M; Arihiro K; Kataoka T; Okajima M; Asahara T
Oncol Rep; 2005 Dec; 14(6):1437-43. PubMed ID: 16273236
[TBL] [Abstract][Full Text] [Related]
38. [Expression of KIF18A in gastric cancer and its association with prognosis].
Wang L; Yang S; Sun R; Lu M; Wu Y; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):585-9. PubMed ID: 27215532
[TBL] [Abstract][Full Text] [Related]
39. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
[TBL] [Abstract][Full Text] [Related]
40. Kinesin family member 3A induces related diseases via wingless-related integration site/β-catenin signaling pathway.
Liu S; He Y; Li S; Gao X; Yang F
Sci Prog; 2023; 106(1):368504221148340. PubMed ID: 36594221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]